James Galt PhD
Overview
James Galt, Ph.D. is the Director of Nuclear Medicine Physics at Emory University Hospital, where he has served as the Division of Nuclear Medicines primary clinical physicist and directed the physics course for nuclear medicine and nuclear cardiology residents since 1998. Before moving to Emory, he served as the Physicist and Assistant Chief of the Nuclear Medicine Service of the Veterans Affairs Medical Center (Atlanta) for nine years. He maintains active service at the national level with organizations including the Society for Nuclear Medicine and Molecular Imaging, for which he served as president of the Physics, Instrumentation and Data Sciences Council.
Academic Appointment
- Professor, Radiology and Imaging Sciences, Emory University School of Medicine
Education
Degrees
- Doctor of Philosophy from Emory University
- BS from Emory University
- MS from Georgia Institute of Technology
Research
Focus
- Dr. Galts research focuses on quantitative emission computed tomography [Single-photon emission tomography (SPECT) and positron emission tomography (PET)] imaging with emphasis on corrections for photon attenuation, Compton scatter, and resolution effects; utilization of SPECT and PET images for planning of radionuclide based therapy; and correlation of SPECT and PET images with other imaging modalities.
Publications
-
AI in Action: A Roadmap from the Radiology AI Council for Effective Model Evaluation and Deployment.
J Am Coll Radiol
05/23/2025 Authors: Trivedi H; Khosravi B; Gichoya J; Benson L; Dyckman D; Galt J; Howard B; Kikano E; Kunjummen J; Lall N -
Resin-Based 90 Y Tumor Dose as a Predictor of Duration of Response and Survival in Patients With Surgically Unresectable Hepatocellular Carcinoma : A Prospective Single-Arm Study.
Clin Nucl Med Volume: 49 Page(s): 799 - 805
09/01/2024 Authors: Kokabi N; Webster LA; Dabbous H; Shah A; Brandon D; Galt J; Xing M; Villalobos A; Davarpanahfakhr A; Kappadath SC -
Myocardial perfusion imaging-derived left ventricular strain: Regional abnormalities associated with transthyretin cardiac amyloidosis.
Am Heart J Plus Volume: 40 Page(s): 100377
04/01/2024 Authors: Lewis S; Huang J; Patel N; Folks R; Galt J; Cooke CD; Zheng Z; Zhang R; Garcia E; Nye J -
Voxel-based dosimetry predicting treatment response and related toxicity in HCC patients treated with resin-based Y90 radioembolization: a prospective, single-arm study.
Eur J Nucl Med Mol Imaging Volume: 50 Page(s): 1743 - 1752
05/01/2023 Authors: Kokabi N; Arndt-Webster L; Chen B; Brandon D; Sethi I; Davarpanahfakhr A; Galt J; Elsayed M; Bercu Z; Cristescu M -
Accuracy and Safety of Scout Dose Resin Yttrium-90 Microspheres for Radioembolization Therapy Treatment Planning: A Prospective Single-Arm Clinical Trial.
J Vasc Interv Radiol Volume: 33 Page(s): 1578 - 1587.e5
12/01/2022 Authors: Kokabi N; Webster LA; Elsayed M; Switchenko JM; Chen B; Brandon D; Galt J; Sethi I; Cristescu M; Kappadath SC -
Determination of Tumor Dose Response Thresholds in Patients with Chemorefractory Intrahepatic Cholangiocarcinoma Treated with Resin and Glass-based Y90 Radioembolization.
Cardiovasc Intervent Radiol Volume: 44 Page(s): 1194 - 1203
08/01/2021 Authors: Cheng B; Villalobos A; Sethi I; Wagstaff W; Galt J; Brandon D; Schuster DM; Bercu Z; Majdalany B; Kokabi N -
Same day yttrium-90 radioembolization with single photon emission computed tomography/computed tomography: An opportunity to improve care during the COVID-19 pandemic and beyond.
World J Gastrointest Oncol Volume: 13 Page(s): 440 - 452
05/15/2021 Authors: Elsayed M; Loya M; Galt J; Schuster DM; Bercu ZL; Newsome J; Brandon D; Benenati S; Behbahani K; Duszak R -
Tumor-to-Normal Ratio Relationship between Planning Technetium-99 Macroaggregated Albumin and Posttherapy Yttrium-90 Bremsstrahlung SPECT/CT.
J Vasc Interv Radiol Volume: 32 Page(s): 752 - 760
05/01/2021 Authors: Villalobos A; Cheng B; Wagstaff W; Sethi I; Bercu Z; Schuster DM; Brandon DC; Galt J; Kokabi N -
Yttrium-90 dosimetry and implications on tumour response and survival after radioembolisation of chemo-refractory hepatic metastases from breast cancer.
Nucl Med Commun Volume: 42 Page(s): 402 - 409
04/01/2021 Authors: Cheng B; Sethi I; Davisson N; Brandon D; Barron B; Galt J; Bercu Z; Schuster DM; Kokabi N -
Comparison of Tc-99m MAA Planar Versus SPECT/CT Imaging for Lung Shunt Fraction Evaluation Prior to Y-90 Radioembolization: Are We Overestimating Lung Shunt Fraction?
Cardiovasc Intervent Radiol Volume: 44 Page(s): 254 - 260
02/01/2021 Authors: Elsayed M; Cheng B; Xing M; Sethi I; Brandon D; Schuster DM; Bercu Z; Galt J; Barron B; Kokabi N